The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on “high risk” products.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including a new management team at a NextPharma site and appointments at Quintiles.
In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its manufacturing team and Carl Icahn’s representative joining Adventrex’s board.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments PharmaNet, Cardinal Health, CTI, Norwich, Diteba and Catalent.
BioStorage Technologies has come up with a novel solution to cold-chain transport, launching a mobile biorepository that is capable of transporting samples across the continental US on a single tank of fuel.
Contract services major Quintiles will sell Movetis’ chronic constipation treatment Resolor (prucalopride) in Europe under a contract announced last week.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Vasella stepping down as CEO of Novartis and appointments at Shionogi Pharma and Antares Pharma.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Synexus, INC and a Quintiles executive being elected at CDISC.
Emergency relief groups in Haiti can expect to receive continued support from the drug industry, according to the International Federation of Pharmaceutical Manufacturers (IFPMA).
Microbiology testing company Nelson Laboratories has completed its 50,000 sq ft expansion and estimated it will create as many as 300 jobs over the next decade, with up to 100 appointments being made this year.
The EFPIA’s European Vaccine Manufacturers (EVM) group has denied allegations that its members were involved in hyping up the threat of the H1N1 pandemic to boost vaccine sales.
The subsidy package used to attract Amylin to Ohio was probably too large and inflated by the biotech’s claim it was considering other locations, according to a report which calls for an end to the “economic war among states”.
Global vaccine revenues will be $52bn (€36.2bn) in 2016, more than double the total for 2009, driven by new products and indication expansions of established therapies, according to a report.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Cel-Sci strengthening its manufacturing team and three promotions at Adolor.
Cambridge Consultants (CC) says experience developing auto-injector technologies was critical to its contract appraisal work during Consort Medical’s £16.8m (€11.5m) takeover of The Medical House (TMH).
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its quality team and appointments at ISPE and Biogen Idec.
US FDA has missed its review deadline for MannKind’s inhaled insulin candidate Afrezza after failing to complete inspection of third-party contract supplier.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at DPT Laboratories, Datatrak and Dishman.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including the retirement of Biogen Idec’s CEO and appointments at Dishman and Noven.
inVentiv Health claims the acquisition of ParagonRx positions it as the leading supplier of REMS services in the pharmaceutical contract services sector.
Ranbaxy Laboratories has sold its Chinese JV, Ranbaxy Guangzhou China Limited (RGCL), as part of a new approach to the country’s rapidly expanding drug market.
McNeil Consumer Healthcare has recalled all lots of its Tylenol Arthritis Pain caplet 100 count bottles in the US due to reports of nausea and stomach pain.
Novartis intends to acquire the remaining 75 per cent of Alcon for $39.3bn (€27.3bn), adding to the shares it bought in April 2008 and giving the big pharma control of the ophthalmic specialist.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including changes at SRC, Pacific Biometrics, GVK Biosciences and DPT Laboratories.
MedImmune has recalled unused doses of its intranasal H1N1 vaccine FluMist in the US after checks revealed that some had fallen below the minimum potency threshold in the two months since they were shipped.
In-Pharmatechnologist presents its latest round up of movements in the pharma sector, including appointments at Merck & Co, MediGene and Medivation, as well as departures at Bristol-Myers Squibb and KV Pharmaceutical.
Welcome to this seasonal holiday video from Decision News Media.As we prepare to celebrate our tenth anniversary next year and first year as part of William Reed Business Media, we present 10 fun number facts about our company. And, later this week, the...
Sanofi Pasteur has recalled four lots of its pediatric H1N1 vaccine in the US that were found to have fallen below potency limits despite being be in spec at the time of manufacture.
GSK says UK plans to apply a reduced tax rate to all drugs patented after 2013 will encourage investment, provided it is applied to products already being developed.
GSK halted production in Rajahmundry, India and Eisai postponed the opening of a facility in nearby Vizag on Saturday after days of unrest over plans to create a new state, Telangana, within Andhra Pradesh.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Genzyme, Amarin and Hard To Treat Diseases.
Kaulkin Information Systems (KIS) is launching SaaS KISTrack TrackHealth to help pharma and healthcare staff monitor, manage and share electronic health records (EHR).
Officials carried out another set of surprise inspections at pharma companies yesterday, in the latest stage of the European Commission's clampdown on anti-competitive practices.
The EU industry commissioner has said the scale of pharmaceutical counterfeiting “exceeded our worst fears” and the EPHA has weighed into the debate on the development of the draft directive.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, Chiltern and Cardinal Health.
inVentiv Health has rolled-out FlightPath, a new bespoke service designed to help pharmaceutical and biotechnology companies chart a clear course to commercial launch.
Watson Pharmaceuticals gained US rights to market a generic version of Lipitor (atorvastatin) in 2011 with the acquisition of non-branded drugmaker Arrow Group late last week.
